BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34153714)

  • 1. Impact of COVID-19 on healthcare organisation and cancer outcomes.
    Bardet A; Fraslin AM; Marghadi J; Borget I; Faron M; Honoré C; Delaloge S; Albiges L; Planchard D; Ducreux M; Hadoux J; Colomba E; Robert C; Bouhir S; Massard C; Micol JB; Ter-Minassian L; Michiels S; Auperin A; Barlesi F; Bonastre J
    Eur J Cancer; 2021 Aug; 153():123-132. PubMed ID: 34153714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials.
    Tabrizi S; Trippa L; Cagney D; Aizer AA; Tanguturi S; Ventz S; Fell G; Bellon JR; Mamon H; Nguyen PL; D'Amico AV; Haas-Kogan D; Alexander BM; Rahman R
    JAMA Netw Open; 2021 Mar; 4(3):e213304. PubMed ID: 33779742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic: A Qualitative Study.
    Gharzai LA; Resnicow K; An LC; Jagsi R
    JAMA Oncol; 2020 Sep; 6(9):1424-1428. PubMed ID: 32761102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the impact of the COVID-19 pandemic on tertiary gynaecological cancer care delivery: a population based study.
    Lowe-Zinola J; Williamson M; Gaunt E; Boulter H; Pounds R; Kehoe S; Yap J
    J Obstet Gynaecol; 2022 Nov; 42(8):3692-3700. PubMed ID: 36469698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada.
    Malagón T; Yong JHE; Tope P; Miller WH; Franco EL;
    Int J Cancer; 2022 Apr; 150(8):1244-1254. PubMed ID: 34843106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.
    Coppock D; Baram M; Chang AM; Henwood P; Kubey A; Summer R; Zurlo J; Li M; Hess B
    PLoS One; 2021; 16(6):e0252591. PubMed ID: 34115801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Reminder of Skin Cancer During the COVID-19 Pandemic.
    Šitum M; Filipović N; Buljan M
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Incidence of Oncology Admissions in 75 Helios Hospitals in Germany during the COVID-19 Pandemic.
    Reichardt P; Bollmann A; Hohenstein S; Glass B; Untch M; Reichardt A; Amrein D; Kuhlen R
    Oncol Res Treat; 2021; 44(3):71-75. PubMed ID: 33333506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surge effects and survival to hospital discharge in critical care patients with COVID-19 during the early pandemic: a cohort study.
    Dale CR; Starcher RW; Chang SC; Robicsek A; Parsons G; Goldman JD; Vovan A; Hotchkin D; Gluckman TJ
    Crit Care; 2021 Feb; 25(1):70. PubMed ID: 33596975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
    Mokos M; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
    Ward ZJ; Walbaum M; Walbaum B; Guzman MJ; Jimenez de la Jara J; Nervi B; Atun R
    Lancet Oncol; 2021 Oct; 22(10):1427-1437. PubMed ID: 34487693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of COVID-19-induced depletion of hospital resources in Ontario, Canada.
    Barrett K; Khan YA; Mac S; Ximenes R; Naimark DMJ; Sander B
    CMAJ; 2020 Jun; 192(24):E640-E646. PubMed ID: 32409519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium.
    de Joode K; Tol J; Hamberg P; Cloos M; Kastelijn EA; Borgers JSW; Nuij VJAA; Klaver Y; Herder GJM; Mutsaers PGNJ; Dumoulin DW; Oomen-de Hoop E; van Diemen NGJ; Libourel EJ; Geraedts EJ; Bootsma GP; van der Leest CH; Peerdeman AL; Herbschleb KH; Visser OJ; Bloemendal HJ; van Laarhoven HWM; de Vries EGE; Hendriks LEL; Beerepoot LV; Westgeest HM; van den Berkmortel FWPJ; Haanen JBAG; Dingemans AC; van der Veldt AAM;
    Eur J Cancer; 2022 Jan; 160():261-272. PubMed ID: 34799210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the COVID-19 pandemic on the short-term survival of patients with cancer in Northern Portugal.
    Morais S; Antunes L; Rodrigues J; Fontes F; Bento MJ; Lunet N
    Int J Cancer; 2021 Jul; 149(2):287-296. PubMed ID: 33634852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of in- and outpatient hospital care in Germany during the Covid-19 pandemic insights from the German-wide Helios hospital network.
    Bollmann A; Hohenstein S; Pellissier V; Stengler K; Reichardt P; Ritz JP; Thiele H; Borger MA; Hindricks G; Meier-Hellmann A; Kuhlen R
    PLoS One; 2021; 16(3):e0249251. PubMed ID: 33765096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment delay of head and neck cancers during COVID-19 era in a tertiary care academic hospital: what should we expect?
    De Luca P; Bisogno A; Colacurcio V; Marra P; Cassandro C; Camaioni A; Cassandro E; Scarpa A
    Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):961-965. PubMed ID: 33929609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and Readmission Rates Among Patients With COVID-19 After Discharge From Acute Care Setting With Supplemental Oxygen.
    Banerjee J; Canamar CP; Voyageur C; Tangpraphaphorn S; Lemus A; Coffey C; Wald-Dickler N; Holtom P; Shoenberger J; Bowdish M; Yee HF; Spellberg B
    JAMA Netw Open; 2021 Apr; 4(4):e213990. PubMed ID: 33792728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
    Aktaa S; Wu J; Nadarajah R; Rashid M; de Belder M; Deanfield J; Mamas MA; Gale CP
    Thromb Res; 2021 Jun; 202():17-23. PubMed ID: 33711754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.